I
Impact BioMedical Inc. (IBO)
ASE – Real Time Price. Currency in USD
0.47
-0.01 (-1.05%)
At close: Jun 26, 2026, 4:00 PM EDT
0.49
+0.02 (3.48%)
After-hours: Jun 26, 2026, 7:50 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
ASE – Real Time Price. Currency in USD
0.47
-0.01 (-1.05%)
At close: Jun 26, 2026, 4:00 PM EDT
0.49
+0.02 (3.48%)
After-hours: Jun 26, 2026, 7:50 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Cash reserves $20.0K barely cover the upcoming debt maturities $0.0
Total current liabilities $1.7M surpass Total current assets $377.0K, signaling liquidity issues
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$464.0K limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.22 | 6.05 | 2.0 | |
| Quick ratio | 0.19 | 5.63 | 2.0 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 5.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | 32K | 39K |
| Gross Profit | -1M | -1M | -1M | -2M | -2M |
| Operating Income | -3M | -4M | -3M | -4M | -6M |
| Net Income | -7M | -4M | -25M | -12M | -13M |
| EBITDA | -2M | -3M | -2M | -3M | -4M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 0 | -143.59 | N/A | -568.68 | 1.0 |
| Y/Y | 999 | -80.5 | N/A | 31.96 | 5.5 |
| 3y average | 999 | -126.4 | N/A | 6.79 | 4.3 |
| 5y average | 999 | -187.68 | N/A | -25.88 | 3.3 |
| Weighted average score | 3.5 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |